Futura Medical plc (LON:FUM – Get Free Report) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 16.22 ($0.22) and traded as low as GBX 8 ($0.11). Futura Medical shares last traded at GBX 8.52 ($0.12), with a volume of 399,535 shares.
Futura Medical Trading Down 4.2%
The stock’s 50-day moving average is GBX 8.99 and its 200-day moving average is GBX 16.22. The stock has a market cap of £25.18 million, a price-to-earnings ratio of -6.66 and a beta of 1.25.
Futura Medical (LON:FUM – Get Free Report) last posted its earnings results on Tuesday, April 15th. The company reported GBX 0.43 ($0.01) earnings per share (EPS) for the quarter. Futura Medical had a negative net margin of 44.64% and a negative return on equity of 56.44%. On average, equities analysts predict that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.
About Futura Medical
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Featured Stories
- Five stocks we like better than Futura Medical
- How is Compound Interest Calculated?
- Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom
- How to Capture the Benefits of Dividend Increases
- Uber and Tesla Surge on Robotaxis, Analyst Touts Texas Rides
- Using the MarketBeat Dividend Yield Calculator
- ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.